# EDGAR Filing Document

**Accession Number:** 0000276914
**File Stem:** 0001410368-26-068154
**Filing Date:** 2026-6
**Character Count:** 56903
**Document Hash:** 68aadfe698d0c639bf2a360173c0baca
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001410368-26-068154.hdr.sgml**: 20260629

**ACCESSION NUMBER**: 0001410368-26-068154

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20260430

**FILED AS OF DATE**: 20260629

**DATE AS OF CHANGE**: 20260629

**PERIOD START**: 20260731

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** LORD ABBETT DEVELOPING GROWTH FUND, INC.
- **CENTRAL INDEX KEY:** 0000276914

**ORGANIZATION NAME:**
- **EIN:** 132958970
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 0731

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-02871
- **FILM NUMBER:** 261132411

**BUSINESS ADDRESS:**
- **STREET 1:** 30 HUDSON ST.
- **CITY:** JERSEY CITY
- **STATE:** NJ
- **ZIP:** 07302
- **BUSINESS PHONE:** 201-827-2000

**MAIL ADDRESS:**
- **STREET 1:** 30 HUDSON ST.
- **CITY:** JERSEY CITY
- **STATE:** NJ
- **ZIP:** 07302

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LORD ABBETT DEVELOPING GROWTH FUND INC /NEW/
- **DATE OF NAME CHANGE:** 19920703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DEVELOPING GROWTH SHARES INC
- **DATE OF NAME CHANGE:** 19600201

## Series and Classes Contracts Data

### LORD ABBETT DEVELOPING GROWTH FUND INC (Series ID: S000006834)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000018473 | Class A      | LAGWX           |
| C000018475 | Class C      | LADCX           |
| C000018476 | Class P      | LADPX           |
| C000018477 | Class I      | LADYX           |
| C000054855 | Class F      | LADFX           |
| C000054856 | Class R2     | LADQX           |
| C000054857 | Class R3     | LADRX           |
| C000151972 | Class R4     | LADSX           |
| C000151973 | Class R5     | LADTX           |
| C000151974 | Class R6     | LADVX           |
| C000188220 | Class F3     | LOGWX           |

## Nport-Ex

![](x3_c116323x1x1.jpg)

Lord Abbett

Quarterly Portfolio Holdings Report

Lord Abbett <br> Developing Growth Fund

*For the period ended April 30, 2026*

**Schedule of Investments (unaudited)**

*April 30, 2026*

---

| | | |
|:---|:---|:---|
| **Investments** | **Shares** | **Fair<br> Value** |
| **LONG-TERM INVESTMENTS 99.76%** |  |  |
| **COMMON STOCKS 99.76%** |  |  |
| **Aerospace & Defense 10.25%** |  |  |
| Aevex Corp. Class A\* | 467466 | $14140847 |
| Carpenter Technology Corp. | 108256 | 46355219 |
| FTAI Aviation Ltd. | 73746 | 18412164 |
| Karman Holdings, Inc.\* | 371888 | 25280946 |
| Kratos Defense & Security Solutions, Inc.\* | 330915 | 20864191 |
| Mercury Systems, Inc.\* | 325284 | 25668160 |
| Moog, Inc. Class A | 33919 | 10220134 |
| Rocket Lab Corp.\* | 180888 | 14925069 |
| VSE Corp. | 118451 | 20335668 |
| Woodward, Inc. | 49819 | 18083799 |
| York Space Systems, Inc.\*<sup>(a)</sup> | 387959 | 12864720 |
| *Total* |  | 227150917 |
| **Beverages 1.53%** |  |  |
| Celsius Holdings, Inc.\* | 301688 | 10127666 |
| Vita Coco Co., Inc.\* | 359992 | 23755872 |
| *Total* |  | 33883538 |
| **Biotechnology 15.67%** |  |  |
| Abivax SA ADR\* | 183074 | 21489226 |
| Arrowhead Pharmaceuticals, Inc.\* | 223850 | 16448498 |
| Ascendis Pharma AS (Denmark)\*<sup>(a)(b)</sup> | 84934 | 19482161 |
| Bridgebio Pharma, Inc.\* | 554755 | 39448628 |
| Celcuity, Inc.\* | 188321 | 22852753 |
| CG oncology, Inc.\* | 204698 | 13661544 |
| Cogent Biosciences, Inc.\* | 663487 | 23746200 |
| Dianthus Therapeutics, Inc.\* | 115645 | 10153631 |
| Madrigal Pharmaceuticals, Inc.\* | 82089 | 42472028 |
| Mirum Pharmaceuticals, Inc.\* | 263316 | 25623280 |
| Natera, Inc.\* | 83160 | 17144266 |
| Nuvalent, Inc. Class A\* | 91136 | 9139118 |
| Oruka Therapeutics, Inc.\* | 214960 | 14705414 |

---

---

| | | |
|:---|:---|:---|
| **Investments** | **Shares** | **Fair<br> Value** |
| **Biotechnology (continued)** |  |  |
| Protagonist Therapeutics, Inc.\* | 138522 | $13709522 |
| PTC Therapeutics, Inc.\* | 330938 | 21530826 |
| Revolution Medicines, Inc.\* | 133298 | 19210908 |
| Rhythm Pharmaceuticals, Inc.\* | 201474 | 16391925 |
| *Total* |  | 347209928 |
| **Building Products 2.42%** |  |  |
| Madison Air Solutions Corp. Class A\*<sup>(a)</sup> | 345499 | 13191152 |
| Modine Manufacturing Co.\* | 158948 | 40472929 |
| *Total* |  | 53664081 |
| **Capital Markets 2.69%** |  |  |
| Evercore, Inc. Class A | 51981 | 16700976 |
| Miami International Holdings, Inc.\* | 472654 | 21973684 |
| Piper Sandler Cos. | 240796 | 20997411 |
| *Total* |  | 59672071 |
| **Construction & Engineering 14.16%** | **Construction & Engineering 14.16%** |  |
| Argan, Inc. | 44171 | 29593687 |
| Cardinal Infrastructure Group, Inc. Class A\*<sup>(a)</sup> | 422602 | 22410584 |
| Comfort Systems USA, Inc. | 43377 | 79824524 |
| Construction Partners, Inc. Class A\* | 274632 | 33960993 |
| IES Holdings, Inc.\* | 43441 | 27979479 |
| Legence Corp. Class A\* | 269776 | 23459721 |
| MasTec, Inc.\* | 88631 | 34925046 |
| Sterling Infrastructure, Inc.\* | 119486 | 61609371 |
| *Total* |  | 313763405 |
| **Diversified Consumer Services 1.59%** | **Diversified Consumer Services 1.59%** |  |
| Lincoln Educational Services Corp.\* | 233414 | 9602652 |
| Universal Technical Institute, Inc.\* | 679600 | 25505388 |
| *Total* |  | 35108040 |

---

<br> *See Notes to Schedule of Investments.* 1

**Schedule of Investments (unaudited)(continued)**

*April 30, 2026*

---

| | | | |
|:---|:---|:---|:---|
| **Investments** | **Shares** | **Fair<br> Value** | **Fair<br> Value** |
| **Electrical Equipment 4.77%** |  |  |  |
| Bloom Energy Corp. Class A\* | 253478 | $| 71825526 |
| Nextpower, Inc. Class A\* | 284957 |  | 33946927 |
| *Total* |  |  | 105772453 |
| **Electronic Equipment, Instruments & Components 7.44%** | **Electronic Equipment, Instruments & Components 7.44%** | **Electronic Equipment, Instruments & Components 7.44%** | **Electronic Equipment, Instruments & Components 7.44%** |
| Bel Fuse, Inc. Class B | 100105 |  | 27612963 |
| Cognex Corp. | 194794 |  | 10813015 |
| Fabrinet (Thailand)\*<sup>(b)</sup> | 72429 |  | 49503049 |
| Littelfuse, Inc. | 57077 |  | 23068811 |
| Sanmina Corp.\* | 97628 |  | 21265331 |
| TTM Technologies, Inc.\* | 205985 |  | 32590947 |
| *Total* |  |  | 164854116 |
| **Entertainment 1.05%** |  |  |  |
| IMAX Corp. (Canada)\*<sup>(b)</sup> | 287198 |  | 10919268 |
| Sphere Entertainment Co.\* | 87014 |  | 12395144 |
| *Total* |  |  | 23314412 |
| **Ground Transportation 0.48%** |  |  |  |
| Saia, Inc.\* | 23712 |  | 10642420 |
| **Health Care Equipment & Supplies 0.83%** | **Health Care Equipment & Supplies 0.83%** |  |  |
| Glaukos Corp.\* | 128426 |  | 18450963 |
| **Health Care Providers & Services 2.36%** | **Health Care Providers & Services 2.36%** |  |  |
| Guardant Health, Inc.\* | 599531 |  | 52207159 |
| **Hotels, Restaurants & Leisure 2.95%** | **Hotels, Restaurants & Leisure 2.95%** |  |  |
| Cava Group, Inc.\* | 330862 |  | 30905820 |
| Life Time Group Holdings, Inc.\* | 385225 |  | 10327882 |
| Navan, Inc. Class A\* | 1381876 |  | 24169011 |
| *Total* |  |  | 65402713 |
| **Information Technology Services 3.10%** |  |  |  |
| Applied Digital Corp.\*<sup>(a)</sup> | 459253 |  | 15729415 |
| DigitalOcean Holdings, Inc.\* | 357040 |  | 34429367 |
| Fastly, Inc. Class A\* | 736488 |  | 18600005 |
| *Total* |  |  | 68758787 |

---

---

| | | | |
|:---|:---|:---|:---|
| **Investments** | **Shares** | **Fair<br> Value** | **Fair<br> Value** |
| **Life Sciences Tools & Services 1.08%** | **Life Sciences Tools & Services 1.08%** |  |  |
| Adaptive Biotechnologies Corp.\* | 1697752 | $| 23938303 |
| **Machinery 2.32%** |  |  |  |
| CECO Environmental Corp.\* | 157848 |  | 11702851 |
| Crane Co. | 50207 |  | 8923290 |
| RBC Bearings, Inc.\* | 51497 |  | 30851338 |
| *Total* |  |  | 51477479 |
| **Metals & Mining 0.49%** |  |  |  |
| MP Materials Corp.\*<sup>(a)</sup> | 165432 |  | 10925129 |
| **Pharmaceuticals 2.26%** |  |  |  |
| Nektar Therapeutics\* | 273886 |  | 23291266 |
| Tarsus Pharmaceuticals, Inc.\* | 420038 |  | 26718617 |
| *Total* |  |  | 50009883 |
| **Professional Services 1.56%** |  |  |  |
| Planet Labs PBC\* | 935837 |  | 34597894 |
| **Semiconductors & Semiconductor Equipment 15.20%** | **Semiconductors & Semiconductor Equipment 15.20%** | **Semiconductors & Semiconductor Equipment 15.20%** | **Semiconductors & Semiconductor Equipment 15.20%** |
| Allegro MicroSystems, Inc.\* | 381986 |  | 18526321 |
| Amkor Technology, Inc. | 326850 |  | 22797788 |
| Astera Labs, Inc.\* | 97006 |  | 18890948 |
| Credo Technology Group Holding Ltd.\* | 98869 |  | 17204195 |
| Lattice Semiconductor Corp.\* | 307882 |  | 37647811 |
| MACOM Technology Solutions Holdings, Inc.\* | 183636 |  | 51713734 |
| MKS, Inc. | 63491 |  | 18015571 |
| Nova Ltd. (Israel)\*<sup>(b)</sup> | 88440 |  | 44258029 |
| Rambus, Inc.\* | 161460 |  | 18585661 |
| Semtech Corp.\* | 315364 |  | 33128988 |
| SiTime Corp.\* | 99838 |  | 56123932 |
| *Total* |  |  | 336892978 |
| **Software 5.00%** |  |  |  |
| Cipher Digital, Inc.\* | 922442 |  | 16364121 |
| Clear Secure, Inc. Class A | 330272 |  | 17633222 |

---

<br> 2 *See Notes to Schedule of Investments.*

**Schedule of Investments (unaudited)(continued)**

*April 30, 2026*

---

| | | |
|:---|:---|:---|
| **Investments** | **Shares** | **Fair <br> Value** |
| **Software (continued)** |  |  |
| Guidewire Software, Inc.\* | 73700 | $10199343 |
| Hut 8 Corp.\* | 251529 | 19060868 |
| JFrog Ltd.\* | 337654 | 15680652 |
| ServiceTitan, Inc. Class A\* | 139225 | 8278318 |
| Terawulf, Inc.\*<sup>(a)</sup> | 1082596 | 23524811 |
| *Total* |  | 110741335 |
| **Specialty Retail 0.56%** |  |  |
| Boot Barn Holdings, Inc.\* | 72777 | 12477617 |
| *Total Common Stocks<br> (cost $1,438,416,916)* |  | 2210915621 |
|  | **Principal<br> Amount** |  |
| **SHORT-TERM INVESTMENTS 3.44%** |  |  |
| **REPURCHASE AGREEMENTS 0.53%** |  |  |
| Repurchase Agreement dated 4/30/2026, 3.250% due 5/1/2026 with Fixed Income Clearing Corp. collateralized by $11,804,000 of U.S. Treasury Note at 3.750% due 6/30/2027; value: $11,937,853; proceeds: $11,704,778<br> (cost $11,703,721) | $11703721 | 11703721 |
| **TIME DEPOSITS 0.29%** |  |  |
| CitiBank N.A.<sup>(c)</sup><br> (cost $6,464,672) | 6464672 | 6464672 |

---

---

| | | |
|:---|:---|:---|
| **Investments** | **Shares** | **Fair<br> Value** |
| **MONEY MARKET FUNDS 2.62%** |  |  |
| Fidelity Government Portfolio<sup>(c)</sup><br> (cost $58,182,046) | 58182046 | $58182046 |
| *Total Short-Term Investments*<br> (cost $76,350,439) |  | 76350439 |
| *Total Investments in Securities 103.20%*<br> (cost $1,514,767,355) |  | 2287266060 |
| *Other Assets and Liabilities – Net (3.20)%* |  | (70932552) |
| *Net Assets 100.00%* |  | $2216333508 |

---

---

| | |
|:---|:---|
| ADR | American Depositary Receipt. |
| \* | Non-income producing security. |
| <sup>(a)</sup> | All or a portion of this security is temporarily on loan to unaffiliated broker/dealers. |
| <sup>(b)</sup> | Foreign security traded in U.S. dollars. |
| <sup>(c)</sup> | Security was purchased with the cash collateral from loaned securities. |

---

<br> *See Notes to Schedule of Investments.* 3

**Schedule of Investments (unaudited)(concluded)**

*April 30, 2026*

The following is a summary of the inputs used as of April 30, 2026 in valuing the Fund's investments carried at fair value<sup>(1)</sup>:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Investment Type**<sup>(2)</sup> | **Level 1** | **Level 2** | **Level 3** | **Total** |
| **Long-Term Investments** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Common Stocks | $2210915621 | $– | $– | $2210915621 |
| **Short-Term Investments** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Repurchase Agreements |  | 11703721 |  | 11703721 |
| &nbsp;&nbsp;&nbsp;Time Deposits |  | 6464672 |  | 6464672 |
| &nbsp;&nbsp;&nbsp;Money Market Funds | 58182046 | – | – | 58182046 |
| Total | $2269097667 | $18168393 | $– | $2287266060 |

---

<sup>(1)</sup> Refer to Note 2(a) for a description of fair value measurements and the three-tier hierarchy of inputs.

<sup>(2)</sup> See Schedule of Investments for fair values in each industry and identification of foreign issuers and/or geography. The table above is presented by Investment Type. When applicable, each Level 3 security is identified on the Schedule of Investments along with the valuation technique utilized.

A reconciliation of Level 3 investments is presented when the Fund has a material amount of Level 3 investments at the beginning or end of the period in relation to the Fund's net assets.

4 *See Notes to Schedule of Investments.*

**Notes to Schedule of Investments (unaudited)**

**1.** **ORGANIZATION** 

Lord Abbett Developing Growth Fund, Inc. (the "Fund") is registered under the Investment Company Act of 1940, as amended (the "1940 Act"), as a diversified, open-end management investment company. The Fund was incorporated under Maryland law on August 21, 1978. The Fund's predecessor corporation was organized on July 11, 1973.

**2.** **SIGNIFICANT ACCOUNTING POLICIES** 

(a) **Investment Valuation** **–** Under
 procedures approved by the Fund's Board of Directors (the "Board"), the Board has designated the determination
 of fair value of the Fund's portfolio investments to Lord, Abbett & Co. LLC ("Lord Abbett") as its valuation
 designee. Accordingly, Lord Abbett is responsible for, among
other things, assessing and managing valuation risks, establishing, applying and testing fair value methodologies, and evaluating pricing
services. Lord Abbett has formed a pricing committee (the "Pricing Committee") that performs these responsibilities on behalf
of Lord Abbett, administers the pricing and valuation of portfolio investments and ensures that prices utilized reasonably reflect fair
value. Among other things, these procedures allow Lord Abbett, subject to Board oversight, to utilize independent pricing services, quotations
from securities and financial instrument dealers, and other market sources to determine fair value.

Securities actively traded on any recognized U.S. or non-U.S. exchange or on the NASDAQ Stock Market LLC are valued at the last sale price or official closing price on the exchange or system on which they are principally traded. Events occurring after the close of trading on non-U.S. exchanges may result in adjustments to the valuation of foreign securities to reflect their fair value as of the close of regular trading on the New York Stock Exchange. When valuing foreign equity securities that meet certain criteria, the Pricing Committee uses a third-party fair valuation service that values such securities to reflect market trading that occurs after the close of the applicable foreign markets of comparable securities or other instruments that correlate to the fair-valued securities. Unlisted equity securities are valued at the last quoted sale price or, if no sale price is available, at the mean between the most recently quoted bid and ask prices.

Securities for which prices are not readily available are valued at fair value as determined by the Pricing Committee. The Pricing Committee considers a number of factors, including observable and unobservable inputs, when arriving at fair value. The Pricing Committee may use related or comparable assets or liabilities, recent transactions, market multiples, book values, and other relevant information to determine the fair value of portfolio investments. The Board or a designated committee thereof periodically reviews reports that may include fair value determinations made by the Pricing Committee, related market activity, inputs and assumptions, and retrospective comparison of prices of subsequent purchases and sales transactions to fair value determinations made by the Pricing Committee.

Short-term securities with 60 days or less remaining to maturity are valued using the amortized cost method, which approximates fair value. Investments in open-end money market mutual funds are valued at their net asset value as of the close of each business day.

**Notes to Schedule of Investments (unaudited)(continued)**

**Fair Value Measurements** **–**Fair value is defined as the price that the Fund would receive upon selling an investment or transferring a liability in an orderly transaction to an independent buyer in the principal or most advantageous market of the investment. A three-tier hierarchy is used to maximize the use of observable market data and minimize the use of unobservable inputs and to establish classification of fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability, including assumptions about risk - for example, the risk inherent in a particular valuation technique used to measure fair value (such as a pricing model) and/or the risk inherent in the inputs to the valuation technique. Inputs may be observable or unobservable. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability. Observable inputs are based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the reporting entity's own assumptions about the assumptions market participants would use in pricing the asset or liability. Unobservable inputs are based on the best information available in the circumstances. The three-tier hierarchy classification is determined based on the lowest level of inputs that is significant to the fair value measurement, and is summarized in the three broad Levels listed below:

● Level 1 – unadjusted quoted prices in active markets for identical investments;

● Level 2 – other significant observable inputs (including quoted prices for similar
 investments, interest rates, prepayment speeds, credit risk, etc.); and

● Level 3 – significant unobservable inputs (including the Fund's own assumptions
 in determining the fair value of investments).

A summary of inputs used in valuing the Fund's investments as of April 30, 2026 and, if applicable, Level 3 rollforwards for the period then ended is included in the Fund's Schedule of Investments.

Changes in valuation techniques may result in transfers into or out of an assigned level within the three-tier hierarchy. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

**3.** **FEDERAL TAX INFORMATION** 

It is the policy of the Fund to meet the requirements of Subchapter M of the Internal Revenue Code of 1986, as amended, applicable to regulated investment companies and to distribute substantially all taxable income and capital gains to its shareholders. Therefore, no income tax provision is required.

The Fund files U.S. federal and various state and local tax returns. No income tax returns are currently under examination. The statute of limitations on the Fund's filed U.S. federal tax returns remains open generally three years after the filing of the tax return. The statutes of limitations on the Fund's state and local tax returns may remain open for an additional year depending upon the jurisdiction.

**Notes to Schedule of Investments (unaudited)(concluded)**

**4.** **SECURITIES LENDING AGREEMENT** 

The Fund has established a securities lending agreement with Citibank, N.A. for the lending of securities to qualified brokers in exchange for securities or cash collateral equal to at least the market value of securities loaned, plus interest, if applicable. Cash collateral is invested in an approved money market fund. In accordance with the Fund's securities lending agreement, the market value of securities on loan is determined each day at the close of business and any additional collateral required to cover the value of securities on loan is delivered to the Fund on the next business day. As with other extensions of credit, the Fund may experience a delay in the recovery of its securities or incur a loss should the borrower of the securities breach its agreement with the Fund or the borrower becomes insolvent at a time when the collateral is insufficient to cover the cost of repurchasing securities on loan.

The initial collateral received by the Fund is required to have a value equal to at least 100% of the market value of the securities loaned. The collateral must be marked-to-market daily to cover increases in the market value of the securities loaned (or potentially a decline in the value of the collateral). In general, the risk of borrower default will be borne by Citibank, N.A.; the Fund will bear the risk of loss with respect to the investment of the cash collateral. The advantage of such loans is that the Fund continues to receive income on loaned securities while receiving a portion of any securities lending fees and earning returns on the cash amounts which may be reinvested for the purchase of investments in securities.

As of April 30, 2026, the market value of securities loaned and collateral received were as follows:

---

| | |
|:---|:---|
| **Market Value of<br> Securities Loaned** | **Collateral Received** |
| $67708020 | $64646718 |

---

QPHR-DEV-3Q

(6/26)

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** LORD ABBETT DEVELOPING GROWTH FUND, INC.

- **b. Investment Company Act file number:** 811-02871

- **c. CIK number of Registrant:** 0000276914

- **d. LEI of Registrant:** 549300HWJ2W28SDTJF85

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 30 HUDSON STREET

  - **City:** JERSEY CITY

  - **State:** NJ

  - **Foreign country:** US

  - **Zip / Postal Code:** 07302

  - **Telephone number:** 201-827-2000

**Item A.2. Information about the Series.**

- **a. Name of Series:** LORD ABBETT DEVELOPING GROWTH FUND INC

- **b. EDGAR series identifier (if any):** S000006834

- **c. LEI of Series:** 549300HWJ2W28SDTJF85

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-07-31

- **b. Date as of which information is reported:** 2026-04-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $2287358159.85

**Total Liabilities:** $66933516.42

**Net Assets:** $2220424643.43

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000188220 | 0.11%                | -4.22%               | 17.62%               |
| Class ID C000018475 | 0.08%                | -4.33%               | 17.46%               |
| Class ID C000151974 | 0.11%                | -4.25%               | 17.63%               |
| Class ID C000151972 | 0.08%                | -4.24%               | 17.58%               |
| Class ID C000054856 | 0.04%                | -4.26%               | 17.53%               |
| Class ID C000151973 | 0.11%                | -4.26%               | 17.63%               |
| Class ID C000018473 | 0.08%                | -4.28%               | 17.61%               |
| Class ID C000018476 | 0.04%                | -4.24%               | 17.55%               |
| Class ID C000018477 | 0.09%                | -4.23%               | 17.59%               |
| Class ID C000054857 | 0.08%                | -4.28%               | 17.58%               |
| Class ID C000054855 | 0.07%                | -4.25%               | 17.65%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $8070687.88              | $-5289447.01                               |
| Month 2  | $47310022.62             | $-131986687.13                             |
| Month 3  | $31192822.67             | $304318657.01                              |

### Schedule of Portfolio Investments

| Name                                    | Title                                                  | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Carpenter Technology Corp               | Carpenter Technology Corp                              | CUSIP: 144285103<br>LEI: DX6I6ZD3X5WNNCDJKP85 | Long             | EC               | CORP              | US        |    108256 | NS      | $46355219.20  | 2.09%             |  |  |  | No            |                  1 | On Loan: No      |
| TTM Technologies Inc                    | TTM Technologies Inc                                   | CUSIP: 87305R109<br>LEI: 549300SC4BDOIS008048 | Long             | EC               | CORP              | US        |    205985 | NS      | $32590946.70  | 1.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Astera Labs Inc                         | Astera Labs Inc                                        | CUSIP: 04626A103<br>LEI: 529900LJL8TUEGF7HG20 | Long             | EC               | CORP              | US        |     97006 | NS      | $18890948.44  | 0.85%             |  |  |  | No            |                  1 | On Loan: No      |
| Nova Ltd                                | Nova Ltd                                               | CUSIP: 000000000<br>LEI: 529900B2DSWE5V3SC292 | Long             | EC               | CORP              | IL        |     88440 | NS      | $44258029.20  | 1.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Arrowhead Pharmaceuticals Inc           | Arrowhead Pharmaceuticals Inc                          | CUSIP: 04280A100<br>LEI: 549300O3CSB8T7OZ3D66 | Long             | EC               | CORP              | US        |    223850 | NS      | $16448498.00  | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Hut 8 Corp                              | Hut 8 Corp                                             | CUSIP: 44812J104<br>LEI: 98450066FEF9C1D3FC20 | Long             | EC               | CORP              | US        |    251529 | NS      | $19060867.62  | 0.86%             |  |  |  | No            |                  1 | On Loan: No      |
| DigitalOcean Holdings Inc               | DigitalOcean Holdings Inc                              | CUSIP: 25402D102<br>LEI: 549300EPISPY3RE3DL21 | Long             | EC               | CORP              | US        |    357040 | NS      | $34429367.20  | 1.55%             |  |  |  | No            |                  1 | On Loan: No      |
| Protagonist Therapeutics Inc            | Protagonist Therapeutics Inc                           | CUSIP: 74366E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    138522 | NS      | $13709522.34  | 0.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Rhythm Pharmaceuticals Inc              | Rhythm Pharmaceuticals Inc                             | CUSIP: 76243J105<br>LEI: 529900JPNWXQ8DPLA551 | Long             | EC               | CORP              | US        |    201474 | NS      | $16391924.64  | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Evercore Inc                            | Evercore Inc                                           | CUSIP: 29977A105<br>LEI: 529900P6KLPT95DW3W58 | Long             | EC               | CORP              | US        |     51981 | NS      | $16700975.49  | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Amkor Technology Inc                    | Amkor Technology Inc                                   | CUSIP: 031652100<br>LEI: 529900VHLRTKPWZJBM84 | Long             | EC               | CORP              | US        |    326850 | NS      | $22797787.50  | 1.03%             |  |  |  | No            |                  1 | On Loan: No      |
| VSE Corp                                | VSE Corp                                               | CUSIP: 918284100<br>LEI: 549300QWJYQDH4U5XI15 | Long             | EC               | CORP              | US        |    118451 | NS      | $20335667.68  | 0.92%             |  |  |  | No            |                  1 | On Loan: No      |
| RBC Bearings Inc                        | RBC Bearings Inc                                       | CUSIP: 75524B104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     51497 | NS      | $30851337.73  | 1.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Semtech Corp                            | Semtech Corp                                           | CUSIP: 816850101<br>LEI: 549300J7WUY317SW6O61 | Long             | EC               | CORP              | US        |    315364 | NS      | $33128988.20  | 1.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Ascendis Pharma A/S                     | Ascendis Pharma A/S                                    | CUSIP: 000000000<br>LEI: 549300B66JN3W3J8GH73 | Long             | EC               | CORP              | DK        |     84934 | NS      | $19482160.92  | 0.88%             |  |  |  | No            |                  1 | On Loan: —       |
| Sphere Entertainment Co                 | Sphere Entertainment Co                                | CUSIP: 55826T102<br>LEI: 254900ZW4JWKYRZZ9A91 | Long             | EC               | CORP              | US        |     87014 | NS      | $12395144.30  | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| IES Holdings Inc                        | IES Holdings Inc                                       | CUSIP: 44951W106<br>LEI: 549300687T8E6LN6EN72 | Long             | EC               | CORP              | US        |     43441 | NS      | $27979479.28  | 1.26%             |  |  |  | No            |                  1 | On Loan: No      |
| MACOM Technology Solutions Holdings Inc | MACOM Technology Solutions Holdings Inc                | CUSIP: 55405Y100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    183636 | NS      | $51713733.96  | 2.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Miami International Holdings Inc        | Miami International Holdings Inc                       | CUSIP: 59356Q108<br>LEI: 254900TREUDBWGLAP788 | Long             | EC               | CORP              | US        |    472654 | NS      | $21973684.46  | 0.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Cava Group Inc                          | Cava Group Inc                                         | CUSIP: 148929102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    330862 | NS      | $30905819.42  | 1.39%             |  |  |  | No            |                  1 | On Loan: No      |
| JFrog Ltd                               | JFrog Ltd                                              | CUSIP: 000000000<br>LEI: 2549002N8E00AY49G567 | Long             | EC               | CORP              | IL        |    337654 | NS      | $15680651.76  | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| York Space Systems Inc                  | York Space Systems Inc                                 | CUSIP: 987084100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    387959 | NS      | $12864720.44  | 0.58%             |  |  |  | No            |                  1 | On Loan: —       |
| Oruka Therapeutics Inc                  | Oruka Therapeutics Inc                                 | CUSIP: 687604108<br>LEI: 529900TG7O4ESUDMGI54 | Long             | EC               | CORP              | US        |    214960 | NS      | $14705413.60  | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Adaptive Biotechnologies Corp           | Adaptive Biotechnologies Corp                          | CUSIP: 00650F109<br>LEI: 549300ZTF7OT1FW66Q96 | Long             | EC               | CORP              | US        |   1697752 | NS      | $23938303.20  | 1.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Modine Manufacturing Co                 | Modine Manufacturing Co                                | CUSIP: 607828100<br>LEI: Z35SZFYJR8GZZRSIUU09 | Long             | EC               | CORP              | US        |    158948 | NS      | $40472929.24  | 1.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Madison Air Solutions Corp              | Madison Air Solutions Corp                             | CUSIP: 55658T105<br>LEI: 529900S9J1ZIEU23PX82 | Long             | EC               | CORP              | US        |    345499 | NS      | $13191151.82  | 0.59%             |  |  |  | No            |                  1 | On Loan: —       |
| Boot Barn Holdings Inc                  | Boot Barn Holdings Inc                                 | CUSIP: 099406100<br>LEI: 529900QE1BFMYA3N4E71 | Long             | EC               | CORP              | US        |     72777 | NS      | $12477616.65  | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Madrigal Pharmaceuticals Inc            | Madrigal Pharmaceuticals Inc                           | CUSIP: 558868105<br>LEI: 549300CHIMT2EUSNJB60 | Long             | EC               | CORP              | US        |     82089 | NS      | $42472027.71  | 1.91%             |  |  |  | No            |                  1 | On Loan: No      |
| MasTec Inc                              | MasTec Inc                                             | CUSIP: 576323109<br>LEI: 549300TMDIT8WREDOF45 | Long             | EC               | CORP              | US        |     88631 | NS      | $34925045.55  | 1.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Woodward Inc                            | Woodward Inc                                           | CUSIP: 980745103<br>LEI: YPYKXXTR8TFDH54ZMB45 | Long             | EC               | CORP              | US        |     49819 | NS      | $18083798.81  | 0.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Applied Digital Corp                    | Applied Digital Corp                                   | CUSIP: 038169207<br>LEI: 2549004NE2B6RYXINZ02 | Long             | EC               | CORP              | US        |    459253 | NS      | $15729415.25  | 0.71%             |  |  |  | No            |                  1 | On Loan: —       |
| Fastly Inc                              | Fastly Inc                                             | CUSIP: 31188V100<br>LEI: 549300E2FZC83FJ3H565 | Long             | EC               | CORP              | US        |    736488 | NS      | $18600004.44  | 0.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Revolution Medicines Inc                | Revolution Medicines Inc                               | CUSIP: 76155X100<br>LEI: 549300JU3X0LBCQ65892 | Long             | EC               | CORP              | US        |    133298 | NS      | $19210907.76  | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Comfort Systems USA Inc                 | Comfort Systems USA Inc                                | CUSIP: 199908104<br>LEI: 5299009DT1ZA5HTU6R38 | Long             | EC               | CORP              | US        |     43377 | NS      | $79824524.25  | 3.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Vita Coco Co Inc/The                    | Vita Coco Co Inc/The                                   | CUSIP: 92846Q107<br>LEI: 54930020WXOAWHR85Y25 | Long             | EC               | CORP              | US        |    359992 | NS      | $23755872.08  | 1.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Dianthus Therapeutics Inc               | Dianthus Therapeutics Inc                              | CUSIP: 252828108<br>LEI: 549300Z3N6ODPCOFC890 | Long             | EC               | CORP              | US        |    115645 | NS      | $10153631.00  | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Saia Inc                                | Saia Inc                                               | CUSIP: 78709Y105<br>LEI: 549300WNPG4N9GBOYB29 | Long             | EC               | CORP              | US        |     23712 | NS      | $10642419.84  | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Bloom Energy Corp                       | Bloom Energy Corp                                      | CUSIP: 093712107<br>LEI: 549300XB5J9BFW5JXV97 | Long             | EC               | CORP              | US        |    253478 | NS      | $71825526.08  | 3.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Universal Technical Institute Inc       | Universal Technical Institute Inc                      | CUSIP: 913915104<br>LEI: 2549003YOJGAZ0PVFV48 | Long             | EC               | CORP              | US        |    679600 | NS      | $25505388.00  | 1.15%             |  |  |  | No            |                  1 | On Loan: No      |
| ServiceTitan Inc                        | ServiceTitan Inc                                       | CUSIP: 81764X103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    139225 | NS      | $8278318.50   | 0.37%             |  |  |  | No            |                  1 | On Loan: No      |
| IMAX Corp                               | IMAX Corp                                              | CUSIP: 45245E109<br>LEI: 894500GS1ESLAPZCEI74 | Long             | EC               | CORP              | CA        |    287198 | NS      | $10919267.96  | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Lincoln Educational Services Corp       | Lincoln Educational Services Corp                      | CUSIP: 533535100<br>LEI: 549300BJ55KUY6RG7L98 | Long             | EC               | CORP              | US        |    233414 | NS      | $9602651.96   | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Guidewire Software Inc                  | Guidewire Software Inc                                 | CUSIP: 40171V100<br>LEI: 549300WXSG0J8IXZCK32 | Long             | EC               | CORP              | US        |     73700 | NS      | $10199343.00  | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Tarsus Pharmaceuticals Inc              | Tarsus Pharmaceuticals Inc                             | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    420038 | NS      | $26718617.18  | 1.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Sanmina Corp                            | Sanmina Corp                                           | CUSIP: 801056102<br>LEI: X5K24XLM8QYRXF00EB42 | Long             | EC               | CORP              | US        |     97628 | NS      | $21265330.96  | 0.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Guardant Health Inc                     | Guardant Health Inc                                    | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |    599531 | NS      | $52207159.48  | 2.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Planet Labs PBC                         | Planet Labs PBC                                        | CUSIP: 72703X106<br>LEI: 254900Q7PVI3HTQBRB44 | Long             | EC               | CORP              | US        |    935837 | NS      | $34597893.89  | 1.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Cipher Digital Inc                      | Cipher Digital Inc                                     | CUSIP: 17253J106<br>LEI: 254900QABG5HCQZ28A17 | Long             | EC               | CORP              | US        |    922442 | NS      | $16364121.08  | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Fidelity Investments                    | Fidelity Investments Money Market Government Portfolio | CUSIP: 31607A703<br>LEI: E57ODZWZ7FF32TWEFA76 | Long             | STIV             | RF                | US        |  58182046 | NS      | $58182045.93  | 2.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Rambus Inc                              | Rambus Inc                                             | CUSIP: 750917106<br>LEI: 2549000211GDCQSLV833 | Long             | EC               | CORP              | US        |    161460 | NS      | $18585660.60  | 0.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Construction Partners Inc               | Construction Partners Inc                              | CUSIP: 21044C107<br>LEI: 549300MHLFL4E8JLZU44 | Long             | EC               | CORP              | US        |    274632 | NS      | $33960993.12  | 1.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Rocket Lab Corp                         | Rocket Lab Corp                                        | CUSIP: 773121108<br>LEI: 254900LNRW7906KUMM93 | Long             | EC               | CORP              | US        |    180888 | NS      | $14925068.88  | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Fixed Income Clearing Corp.             | FIXED INC CLEARING CORP.REPO                           | CUSIP: 000000000<br>LEI: 549300H47WTHXPU08X20 | Long             | RA               | CORP              | US        |  11703721 | PA      | $11703721.34  | 0.53%             |  |  |  | No            |                  2 | On Loan: No      |
| Cardinal Infrastructure Group Inc       | Cardinal Infrastructure Group Inc                      | CUSIP: 14154A102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    422602 | NS      | $22410584.06  | 1.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Bel Fuse Inc                            | Bel Fuse Inc                                           | CUSIP: 077347300<br>LEI: 2549009L4XYDBRRY6X39 | Long             | EC               | CORP              | US        |    100105 | NS      | $27612963.20  | 1.24%             |  |  |  | No            |                  1 | On Loan: No      |
| MP Materials Corp                       | MP Materials Corp                                      | CUSIP: 553368101<br>LEI: 89450063PHPS61USMT84 | Long             | EC               | CORP              | US        |    165432 | NS      | $10925129.28  | 0.49%             |  |  |  | No            |                  1 | On Loan: —       |
| CECO Environmental Corp                 | CECO Environmental Corp                                | CUSIP: 125141101<br>LEI: 5493002CZCTL4HGLIY91 | Long             | EC               | CORP              | US        |    157848 | NS      | $11702850.72  | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Cognex Corp                             | Cognex Corp                                            | CUSIP: 192422103<br>LEI: 549300JQTYZCLC43S226 | Long             | EC               | CORP              | US        |    194794 | NS      | $10813014.94  | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Crane Co                                | Crane Co                                               | CUSIP: 224408104<br>LEI: 5493000CQRQOTHUODL75 | Long             | EC               | CORP              | US        |     50207 | NS      | $8923290.11   | 0.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Citibank NA                             | CITIBANK NA DDCA                                       | CUSIP: 000000000<br>LEI: E57ODZWZ7FF32TWEFA76 | Long             | STIV             | RF                | US        |   6464672 | NS      | $6464671.77   | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Littelfuse Inc                          | Littelfuse Inc                                         | CUSIP: 537008104<br>LEI: 549300MY7HLQFYTPCX75 | Long             | EC               | CORP              | US        |     57077 | NS      | $23068811.09  | 1.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Sterling Infrastructure Inc             | Sterling Infrastructure Inc                            | CUSIP: 859241101<br>LEI: 549300RZIK6K1215XU51 | Long             | EC               | CORP              | US        |    119486 | NS      | $61609371.32  | 2.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Bridgebio Pharma Inc                    | Bridgebio Pharma Inc                                   | CUSIP: 10806X102<br>LEI: 54930028YG89VTY2J114 | Long             | EC               | CORP              | US        |    554755 | NS      | $39448628.05  | 1.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvalent Inc                            | Nuvalent Inc                                           | CUSIP: 670703107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     91136 | NS      | $9139118.08   | 0.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Fabrinet                                | Fabrinet                                               | CUSIP: 000000000<br>LEI: 5493004TETZ6IYF7CV44 | Long             | EC               | CORP              | KY        |     72429 | NS      | $49503048.63  | 2.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Credo Technology Group Holding Ltd      | Credo Technology Group Holding Ltd                     | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | KY        |     98869 | NS      | $17204194.69  | 0.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Piper Sandler Cos                       | Piper Sandler Cos                                      | CUSIP: 724078209<br>LEI: QUQDBTUSOAKFEVMRMF78 | Long             | EC               | CORP              | US        |    240796 | NS      | $20997411.20  | 0.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Allegro MicroSystems Inc                | Allegro MicroSystems Inc                               | CUSIP: 01749D105<br>LEI: 54930004TGPV6DR3LE12 | Long             | EC               | CORP              | US        |    381986 | NS      | $18526321.00  | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| MKS Inc                                 | MKS Inc                                                | CUSIP: 55306N104<br>LEI: 549300KEQATBHAGVF505 | Long             | EC               | CORP              | US        |     63491 | NS      | $18015571.25  | 0.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Celcuity Inc                            | Celcuity Inc                                           | CUSIP: 15102K100<br>LEI: 25490070W7UU7W2SEY87 | Long             | EC               | CORP              | US        |    188321 | NS      | $22852753.35  | 1.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Abivax SA                               | Abivax SA                                              | CUSIP: 00370M103<br>LEI: 969500D8TMNB184OJU95 | Long             | EC               | CORP              | FR        |    183074 | NS      | $21489226.12  | 0.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Moog Inc                                | Moog Inc                                               | CUSIP: 615394202<br>LEI: 549300WM2I4U7OBAHG07 | Long             | EC               | CORP              | US        |     33919 | NS      | $10220133.89  | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Nektar Therapeutics                     | Nektar Therapeutics                                    | CUSIP: 640268306<br>LEI: 5299005I24806IOIYE03 | Long             | EC               | CORP              | US        |    273886 | NS      | $23291265.44  | 1.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Cogent Biosciences Inc                  | Cogent Biosciences Inc                                 | CUSIP: 19240Q201<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    663487 | NS      | $23746199.73  | 1.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Natera Inc                              | Natera Inc                                             | CUSIP: 632307104<br>LEI: 529900CQ3OZ0A0VYVU59 | Long             | EC               | CORP              | US        |     83160 | NS      | $17144265.60  | 0.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Nextpower Inc                           | Nextpower Inc                                          | CUSIP: 65290E101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    284957 | NS      | $33946927.41  | 1.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Kratos Defense & Security Solutions Inc | Kratos Defense & Security Solutions Inc                | CUSIP: 50077B207<br>LEI: 5493000EKBN0UY1F3F88 | Long             | EC               | CORP              | US        |    330915 | NS      | $20864190.75  | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Terawulf Inc                            | Terawulf Inc                                           | CUSIP: 88080T104<br>LEI: 254900CVMW1SX2T78A64 | Long             | EC               | CORP              | US        |   1082596 | NS      | $23524811.08  | 1.06%             |  |  |  | No            |                  1 | On Loan: —       |
| SiTime Corp                             | SiTime Corp                                            | CUSIP: 82982T106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     99838 | NS      | $56123931.70  | 2.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Life Time Group Holdings Inc            | Life Time Group Holdings Inc                           | CUSIP: 53190C102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    385225 | NS      | $10327882.25  | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| CG oncology Inc                         | CG oncology Inc                                        | CUSIP: 156944100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    204698 | NS      | $13661544.52  | 0.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Aevex Corp                              | Aevex Corp                                             | CUSIP: 00835T107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    467466 | NS      | $14140846.50  | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Glaukos Corp                            | Glaukos Corp                                           | CUSIP: 377322102<br>LEI: 5299004JA1LHE21M6T14 | Long             | EC               | CORP              | US        |    128426 | NS      | $18450963.42  | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Legence Corp                            | Legence Corp                                           | CUSIP: 52476L109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    269776 | NS      | $23459720.96  | 1.06%             |  |  |  | No            |                  1 | On Loan: No      |
| FTAI Aviation Ltd                       | FTAI Aviation Ltd                                      | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | KY        |     73746 | NS      | $18412163.82  | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Navan Inc                               | Navan Inc                                              | CUSIP: 639193101<br>LEI: 254900RHRK35UPHTGY05 | Long             | EC               | CORP              | US        |   1381876 | NS      | $24169011.24  | 1.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Celsius Holdings Inc                    | Celsius Holdings Inc                                   | CUSIP: 15118V207<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    301688 | NS      | $10127666.16  | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Mercury Systems Inc                     | Mercury Systems Inc                                    | CUSIP: 589378108<br>LEI: 549300P3B84SGK7HH679 | Long             | EC               | CORP              | US        |    325284 | NS      | $25668160.44  | 1.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Lattice Semiconductor Corp              | Lattice Semiconductor Corp                             | CUSIP: 518415104<br>LEI: 549300LRBBPZDQ2II567 | Long             | EC               | CORP              | US        |    307882 | NS      | $37647810.96  | 1.70%             |  |  |  | No            |                  1 | On Loan: No      |
| PTC Therapeutics Inc                    | PTC Therapeutics Inc                                   | CUSIP: 69366J200<br>LEI: 549300UJLWOIWFDGB318 | Long             | EC               | CORP              | US        |    330938 | NS      | $21530826.28  | 0.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Mirum Pharmaceuticals Inc               | Mirum Pharmaceuticals Inc                              | CUSIP: 604749101<br>LEI: 254900YZKR40F7F27K81 | Long             | EC               | CORP              | US        |    263316 | NS      | $25623279.96  | 1.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Clear Secure Inc                        | Clear Secure Inc                                       | CUSIP: 18467V109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    330272 | NS      | $17633222.08  | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Argan Inc                               | Argan Inc                                              | CUSIP: 04010E109<br>LEI: 529900E4KZWBV9KGBS83 | Long             | EC               | CORP              | US        |     44171 | NS      | $29593686.58  | 1.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Karman Holdings Inc                     | Karman Holdings Inc                                    | CUSIP: 485924104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    371888 | NS      | $25280946.24  | 1.14%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-05-28

**Name of Applicant:** LORD ABBETT DEVELOPING GROWTH FUND, INC.

**Signature:** Michael Hebert

**Name of Signer:** Michael Hebert

**Title:** Chief Financial Officer